Moors & Cabot, Inc. Novavax Inc Transaction History

Moors & Cabot, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $142,633 - $231,048	-1,060 Closed	0 $0
Q3 2021 Dec 08, 2021	SELL	$177.8 - $270.58 $5.15 Million - $7.83 Million	-28,940 Reduced 96.47%	1,060 $218,000
Q3 2021 Nov 05, 2021	BUY	$177.8 - $270.58 $5.33 Million - $8.12 Million	30,000 New	30,000 $32,000

285

93.8M

5.4M

8.76M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $604M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.